The P2Y1 receptor, necessary but not sufficient to support full ADP- induced platelet aggregation, is not the target of the drug clopidogrel

British Journal of Haematology

Volumn 103, Issue 3, 1998, Pages 858-866

  Hechler, Béatrice ^a   Eckly, Anita ^a   Ohlmann, Philippe ^a   Cazenave, Jean Pierre ^a   Gachet, Christian ^a  

^a INSERM   (France)

Author keywords

33P 2MeSADP binding; Antiplatelet drug; P2 receptor; P2T

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM ION; CLOPIDOGREL; PURINE P2Y RECEPTOR; ADENYLATE CYCLASE; ANTITHROMBOCYTIC AGENT; CALCIUM; DRUG DERIVATIVE; PURINE P2 RECEPTOR; PURINE P2Y1 RECEPTOR; TICLOPIDINE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG TARGETING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; THROMBOCYTE AGGREGATION; ANIMAL; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; ANIMALS; CALCIUM; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; TICLOPIDINE;

EID: 0031593698     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01056.x     Document Type: Article

References (44)

1. Bhagwat, S.S. & William, M. (1997) P2 purine and pyrimidine receptors: emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptors. European Journal of Medicinal Chemistry, 32, 183-193.
2. 1 receptor. Molecular Pharmacology, 50, 1323-1329.
3. Cazenave, J.P., Hemmendinger, S., Beretz, A., Sutter-Bay, A. & Launay, J. (1983) L'agrégation plaquettaire: outil d'investigation clinique et d'étude pharmacologique. Méthodologie. Annales de Biologie Clinique, 41, 167-179.
4. 1 receptor, an adenosine triphosphate-gated cation channel is expressed in human platelets but not in human blood leukocytes. Blood, 91, 3172-3181.
5. Communi, D., Govaerts, C., Parmentier, M. & Boeynaems, J.M. (1998) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. Journal of Biological Chemistry, 272, 31969-31973.
6. Daniel, J.L., Dangelmaier, C.A., Jin, J., Ashby, B., Smith, J.B. & Kunapuli, S.P. (1998) Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. Journal of Biological Chemistry, 273, 2024-2029.
7. Daniel, J.L., Dangelmaier, C.A., Selak, M. & Smith, J.B. (1986) ADP stimulates IP3 formation in human platelets. FEBS Letters, 206, 299-303.
8. 1-activated platelet adenylate cyclase in rats and rabbits. Thrombosis and Haemostasis, 65, 186-190.
9. Gaardner, A., Jonsen, J., Laland, S., Hellem, A. & Owen, P.A. (1961) Adenosine diphosphate in red cells as a factor in adhesiveness of human blood platelets. Nature, 192, 531-532.
10. Gachet, C., Cattaneo, M., Ohlmann, P., Hechler, B., Lecchi, A., Chevalier, J., Cassel, D., Mannucci, P.M. & Cazenave, J.P. (1995) Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. British Journal of Haematology, 91, 434-444.
11. 1. Biochemical Pharmacology, 40, 2683-2687.
12. Gachet, C., Cazenave, J.P., Ohlmann, P., Hilf, G., Wieland, T. & Jakobs, K.H. (1992) ADP receptor-induced activation of guanine-nucleotide-binding proteins in human platelet membranes. European Journal of Biochemistry, 207, 259-263.
13. Gachet, C., Hechler, B., Leon, C., Vial, C., Leray, C., Ohlmann, P. & Cazenave, J.P. (1997) Activation of ADP receptors and platelet function. Thrombosis and Haemostasis, 78, 271-275.
14. Haslam, R.J. (1973) Interactions of the pharmacological receptors of blood platelets with adenylate cyclase. Series Haematological 6, 333-350.
15. 1 receptor is necessary for ADP-induced platelet aggregation. Blood, 92, 152-159.
16. 1 receptor: similarities with the platelet ADP receptor. Molecular Pharmacology, 53, 727-733.
17. Heermskerk, J.W.M. & Sage, S.O. (1994) Calcium signalling in platelets and other cells. Platelets, 5, 295-316.
18. Hellem, A.J. (1960) The adhesiveness of human blood platelets in vitro. Scandinavian Journal of Clinical and Laboratory Investigation. 12, 1-117.
19. Herbert, J.M., Frehel, D., Vallee, E., Kieffer, G., Gouy, D., Berger, Y., Necciari, J., Defreyn, G. & Maffrand, J.P. (1993) Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovascular Drugs Review, 11, 180-198.
20. Hourani, S.M.O. & Hall, D.A. (1996) P2T purinoceptors: ADP receptors on platelets. P2 Purinoceptors: Localization, Function and Transduction Mechanisms, pp. 53-70. Ciba Foundation Symposium 198. Wiley, Chichester.
21. Humphries, R.G., Robertson, M.J. & Leff, P. (1995a) A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends in Pharmacological Sciences, 16, 179-181.
22. Humphries, R.G., Tomlinson, W., Clegg, J.A., Ingall, A.H., Kindon N.D. & Leff, P. (1995h) Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo. British Journal of Pharmacology, 115, 1110-1116.
23. 2T-purinoceptors. British Journal of Pharmacology, 113, 1057-1063.
24. 1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. Journal of Biological Chemistry, 273, 2030-2034.
25. Khym, J.X. (1975) An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers. Clinical Chemistry, 21, 1245-1252.
26. Lanza, F., Beretz, A., Stierle, A., Hanau, D., Kubina, M. & Cazenave, J.P. (1988) Epinephrine potentiates human platelet activation but is not an aggregating agent. American Journal of Physiology, 255, 1276-1288.
27. 1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Letters, 403, 26-30.
28. Macfarlane, D.E. (1987) Agonists and receptors: adenosine diphosphate. Responses and Metabolism (ed. by II. Holmsen), pp. 19-36.
29. 1 not P2T purinoceptors in human platelets. Journal of Biological Chemistry, 271, 2879-2881.
30. Maffrand, J.P., Bernat, A., Delebassee, D., Defreyn, G., Cazenave, J.P. & Gordon, J.L. (1988) ADP plays a key role in thrombogenesis in rats. Thrombosis and Haemostasis, 59, 225-230.
31. Mills, D.C. (1996) ADP receptors on platelets. Thrombosis and Haemostasis, 76, 835-856.
32. Mills, D.C., Puri, R.N., Hu, C.J., Minniti, C., Grana, G., Freedman, M., Colman, R.F. & Colman, R.W. (1992) Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Atherosclerosis and Thrombosis, 12, 430-436.
33. Munson, P.J. & Rodbard, D. (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analytical Biochemistry, 107, 220-239.
34. North, A. & Barnard, E.A. (1997) Nucleotide receptors. Current Opinion in Neurobiology, 7, 346-357.
35. Offermanns, S., Toombs, C.F., Hu, Y.H. & Simon, M.I. (1997) Defective platelet activation in Gαq-deticient mice. Nature, 389, 183-186.
36. Raha, S., Jones, G.D. & Gear, A.R.L. (1993) Sub-second oscillations of inositol 1,4,5-triphosphate and inositol 1,3,4,5-tetrabisphosphate during platelet activation by ADP and thrombin: lack of correlation with calcium kinetics. Biochemical Journal, 292, 643-646.
37. 1 purinoceptor in ADP-induced platelet activation. FEBS Letters, 422, 291-295.
38. 3H]-2-methylthio-ADP to rat platelets: effects of clopidogrel and ticlopidine. Journal of Pharmacology and Experimental Therapeutics, 269, 772-777.
39. 1 purinoceptor expressed on human platelets. Biochemical and Biophysical Research Communications, 2423, 525-528.
40. Schrör, K. (1993) The basic pharmacology of ticlopidine and clopidogrel. Platelets, 4, 252-261.
41. 1 purinoceptor in human platelets. Journal of Biological Chemistry, 273, 11544-11547.
42. 1 purinoceptors in human platelets and megakaryoblastic cell lines. Thrombosis and Haemostasis, 78, 1500-1504.
43. Vickers, J.D., Kinlough-Rathbone, R.L., Packham, M.A. & Mustard, J.F. (1990) Inositol phospholipid metabolism in human platelets stimulated by ADP. European Journal of Biochemistry, 193, 521-528.
44. Williams, M. (1996) Challenges in developing P2 purinoceptor-based therapeutics. P2 Purinoceptor: Localization, Function and Transduction Mechanisms, pp. 309-321. Ciba Foundation Symposium 198. Wiley, Chichester.